Biocon’s S&P Global ESG Score improves to 69 for 2024 EP News Bureau Jan 28, 2025 Biocon’s subsidiary Biocon Biologics, which also participated independently in the assessment for the first time, reported an…
Innovation, partnerships and best practices: Priorities for biopharma in 2025 EP News Bureau Jan 3, 2025 Industry experts highlight the progress made by the Indian biopharma sector, and suggest pathways to promote growth
Biocon receives EIR with VAI status EP News Bureau Dec 9, 2024 This is based on a surveillance inspection conducted by the USFDA between September 23-27, 2024
17th CPHI & PMEC India Expo to highlight advancements in pharma industry EP News Bureau Nov 18, 2024 Event to focus on innovation, sustainability, and India’s growing role in the global pharma sector
Biocon and Dr Reddy’s featured in Science Magazine’s Top Employers List EP News Bureau Oct 30, 2024 This year’s ranking is based on a comprehensive web-based survey of about 6,400 respondents
Biocon signs licensing agreement with Tabuk Pharmaceuticals for GLP-1 products EP News Bureau Sep 27, 2024 Partnership aims to commercialise diabetes and weight management treatments in select Middle Eastern countries
Budget 2024-25 prioritises R&D, education and business for MSMEs EP News Bureau Jul 24, 2024 Industry stakeholders appreciate the efforts made towards increasing employment, skill-building and implementation of various…
Biocon appoints Mukesh Kamnath as interim CFO EP News Bureau Jun 12, 2024 Kamnath is currently the Head of Business Finance R & D at Biocon
Biocon partners with Handok to commercialise Liraglutide in South Korea EP News Bureau May 24, 2024 Biocon to develop and supply Liraglutide; Handok to handle regulatory approval and commercialisation in South Korea.
Biocon signs deal with Medix to market generic Saxenda in Mexico EP News Bureau May 13, 2024 Biocon will undertake the responsibility of obtaining regulatory approval, manufacturing and supply of the drug product, and Medix…